#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pemphigus Epstein-Barr virus infection Chronic graft versus host disease in intestine Basal cell naevus syndrome Hepatic cirrhosis Cardiomyopathy Mucopolysaccharidosis III Microscopic polyangiitis Blastic plasmacytoid dendritic cell neoplasia Frontotemporal dementia Heavy menstrual bleeding Hypomagnesaemia Malignant central nervous system neoplasm Hypersensitivity pneumonitis Usher's syndrome More trials…

    Learn about Rare Diseases

    Cytokine release syndrome – Treatment Glomerulonephritis rapidly progressive – Life with Disease VEXAS syndrome Chronic granulomatous disease Bronchiolitis obliterans syndrome Lysosomal storage disorder – Life with Disease Loeys-Dietz syndrome – Life with Disease Marfan’s syndrome – Diagnostics Carcinoid syndrome – Basic Information Hepatoblastoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Adrenaline Tartrate Ph. Eur. WEF-001 F125/10 Propafenone Hydrochloride Dantrolene Sodium Disulfiram Romosozumab Magnesium Sulfate Mesalazine Dorzolamide Hydrochloride Pamapimod Ide397 Nirmatrelvir Dersimelagon Phosphate Radium Ra 223 Dichloride Ro7247669 A49 Fosaprepitant Nalbuphine Hydrochloride Potassium Canrenoate More therapies…

    Learn about Your Condition

    Lysosomal storage disorder Hepatic fibrosis Herpes simplex meningitis Breast cancer stage III Elderly Anal abscess Hepatic neoplasm Eye pain Arthritis infective Diabetes insipidus Pneumonia chlamydial Macular oedema Myocardial ischaemia Hypersomnia Chordoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Osteosarcoma

  • Cabozantinib Maintenance Therapy vs Best Supportive Care in Osteosarcoma Patients in Complete Remission or with Residual Disease after First‑Line Chemotherapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Cabozantinib
    Denmark Finland France Italy The Netherlands Poland +2

  • A study comparing mifamurtide to sorafenib for treating high-risk osteosarcoma in children and young adults

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Osteosarcoma
    Investigated Drugs:
    • Mifamurtide
    • Sorafenib
    Poland

  • Long-term safety study of GD2IL18CART treatment in patients with neuroblastoma, osteosarcoma, Ewing sarcoma, or advanced breast cancer

    Recruiting

    1 1 1
    Investigated Drugs:
    • Gd2Il18Cart
    Germany

  • Study on the Safety and Dosage of GD2IL18CART for Patients with Relapsed or Refractory GD2 Positive Solid Cancers

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Clemastine Fumarate
    • Gd2Il18Cart
    • Anakinra
    Germany

  • Study of Trabectedin and Low-Dose Radiation Therapy for Adults and Young Adults with Advanced or Metastatic Soft Tissue and Bone Sarcomas

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Chondrosarcoma
    • Osteosarcoma
    • Rhabdomyosarcoma
    Investigated Drugs:
    • Trabectedin
    • Irinotecan Hydrochloride Trihydrate
    Spain

  • Study on Mifamurtide with Chemotherapy for Patients with High-Risk Osteosarcoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Osteosarcoma
    • Osteosarcoma metastatic
    Investigated Drugs:
    • Mifamurtide
    • Cisplatin
    • Doxorubicin Hydrochloride
    France
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!